MGX Metagenomi Therapeutics, Inc.: institutional ownership and insider trading
50 funds reported holding $11.2M of Metagenomi Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net sold $240K, with 4 new positions and 8 funds selling out; over the last 12 months insiders bought $23.4K and sold $33.1K on the open market.
Famous investors holding MGX
- Renaissance Technologies (Renaissance Technologies): $883K, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $611K, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $136K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $21.2K, 0.0% of the portfolio
Largest institutional holders of MGX
- VANGUARD GROUP INC — $2.06M
- Sozo Ventures GP II, L.P. — $1.33M
- VANGUARD CAPITAL MANAGEMENT LLC — $1.28M
- RENAISSANCE TECHNOLOGIES LLC — $883K
- Catalio Capital Management, LP — $630K
- TWO SIGMA INVESTMENTS, LP — $611K
- Peapod Lane Capital LLC — $520K
- BRIDGEWAY CAPITAL MANAGEMENT, LLC — $476K
- WELLS FARGO & COMPANY/MN (WFC, WFCNP, WFC-PA, WFC-PC, WFC-PD, WFC-PL, WFC-PY, WFC-PZ) — $452K
- GEODE CAPITAL MANAGEMENT, LLC — $344K
Recent MGX insider trades
- Sep 9, 2026: Reid Laurence bought 20,000 shares ($23.4K)
- Sep 8, 2026: Wapnick Pamela sold 1,911 shares ($2.22K)
- Sep 8, 2026: Irish Jian sold 2,140 shares ($2.48K)
- Sep 8, 2026: Wein Matthew sold 358 shares ($415)
5%+ owners
- Thomas Brian C.: 7.3% (Schedule 13G, filed Sep 10, 2026)